JENNIFER CLARK: Open Payments
NPI 1649993320 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 60 payments from 18 companies in 2025. Trend: 2023 $1,093 · 2024 $1,367 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $222 |
| Amgen Inc. | 12 | $158 |
| PFIZER INC. | 6 | $136 |
| ABBVIE INC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Astellas Pharma US Inc | 2 | $31 |
Products named: OTEZLA, AIRSUPRA, FARXIGA, REXULTI, LINZESS, JARDIANCE, ELIQUIS, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
